Kiniksa Pharmaceuticals International, plc KNSA Increase Decrease In Operating Lease Liabilities
Increase Decrease In Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept knsa:IncreaseDecreaseInOperatingLeaseLiabilities.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's increase decrease in operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's increase decrease in operating lease liabilities?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported increase decrease in operating lease liabilities of -$993K in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's increase decrease in operating lease liabilities changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's increase decrease in operating lease liabilities decreased by 16.5% year-over-year, from -$852K to -$993K.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's increase decrease in operating lease liabilities?
- Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's increase decrease in operating lease liabilities has grown at a 7.9% compound annual growth rate (CAGR), from -$2.55M to -$3.46M.
- What does increase decrease in operating lease liabilities mean?
- This metric tracks the net change in the company's recognized operating lease liabilities during the reporting period, excluding cash payments. It reflects the impact of new lease agreements, modifications, or the unwinding of existing liabilities on the balance sheet. It is a critical component for assessing how lease-related obligations evolve independently of periodic cash rent payments.